Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Clinical trial NCT00132067 · COMPLETED

Trial details

NCT number: NCT00132067
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer

Start date: 2005-10-01
Primary completion: 2006-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.